Lysosomal Therapeutics' Seed VC Round

Lysosomal Therapeutics raised a round of funding on May 12, 2014.

Lysosomal Therapeutics (LTI) is dedicated to small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases. T…

Articles about Lysosomal Therapeutics' Seed VC Round: